issued
on 30 Jan 2024
Last Applicant/ Owned by
PO Box 309, Ugland House
Grand Cayman
KY
KY1-1104
Serial Number
97778983 filed on 02th Feb 2023
Registration Number
N/A
Correspondent Address
ERIC LAMB
Filing Basis
1. intent to use
2. intent to use current
3. filed as use application
4. use application currently
Disclaimer
NO DATA
Development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of c Read More
Development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates
30th Mar 2021
13th May 2021
Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of antibody-drug conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates
30th Mar 2021
13th May 2021
Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes in the nature of bioconjugate preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions, namely, antibody-drug conjugates in the nature of medical diagnostic reagents; pharmaceutical preparations, namely, drug conjugates consisting primarily of pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease
No 97778983
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
30th Jan 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
05th Dec 2023 | PUBLISHED FOR OPPOSITION |
05th Dec 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
15th Nov 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
01st Nov 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
31st Oct 2023 | ASSIGNED TO EXAMINER |
22nd Feb 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
19th Feb 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
19th Feb 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
19th Feb 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |